Related Experiment Videos

[Frequency of sister chromatid exchange in mice treated with gossypol]

C H Leal-Garza1, M T González-Garza, G Valenciano-Cedillo

  • 1División de Biología Celular, Unidad de Investigación Biomédica del Noreste, IMSS, Monterrey, N.L., México.

Archivos De Investigacion Medica
|July 1, 1990
PubMed

Insights

Gossypol, a male contraceptive, showed a slight increase in sister chromatid exchanges (SCE) in mice, but not a clear dose-response. Further studies are needed to determine its mutagenic potential in humans.

Area of Science:

  • Toxicology
  • Genetics
  • Pharmacology

Background:

  • Gossypol is investigated for male contraceptive properties.
  • Gossypol also exhibits inhibitory effects on parasite growth.
  • Understanding gossypol's safety profile, including mutagenicity, is crucial.

Purpose of the Study:

  • To evaluate the potential mutagenic activity of gossypol.
  • To assess the effect of gossypol on sister chromatid exchanges (SCE) in vivo.

Main Methods:

  • Balb-C mice were administered gossypol via intraesophageal injection at doses of 10, 20, and 30 mg/Kg.
  • The frequency of sister chromatid exchanges (SCE) in bone marrow cells was analyzed.
  • Results were compared to a negative control group.

Main Results:

  • A small increase in the frequency of sister chromatid exchanges (SCE) was observed.
  • No clear dose-response relationship was established.
  • The observed increase was not significant enough to be definitively classified.

Conclusions:

  • Gossypol's mutagenic effect in this study is classified as undetermined or provisionally positive.
  • Further research is essential to ascertain the mutagenic potential of gossypol in humans.
  • Comprehensive safety evaluations are necessary before widespread human use.

Related Concept Videos